These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2412389)

  • 21. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
    Johansen HK; Cryz SJ; Høiby N
    APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A].
    Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
    Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML
    Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
    Cash HA; Straus DC; Bass JA
    Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
    Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
    Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
    Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
    Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)].
    Shinozaki T; Fujii R; Sanai Y; Homma JY
    Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869
    [No Abstract]   [Full Text] [Related]  

  • 32. An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.
    Baer M; Sawa T; Flynn P; Luehrsen K; Martinez D; Wiener-Kronish JP; Yarranton G; Bebbington C
    Infect Immun; 2009 Mar; 77(3):1083-90. PubMed ID: 19103766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
    Fogle MR; Griswold JA; Oliver JW; Hamood AN
    J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
    Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
    Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
    Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
    Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad-spectra human monoclonal antibodies that protect mice infected with Pseudomonas aeruginosa.
    Noguchi H; Yokota S; Ohtsuka H; Kohzuki T; Terashima M; Irie K
    Antibiot Chemother (1971); 1991; 44():172-84. PubMed ID: 1724892
    [No Abstract]   [Full Text] [Related]  

  • 37. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
    Safari Zanjani L; Shapouri R; Dezfulian M; Mahdavi M; Shafiee Ardestani M
    World J Microbiol Biotechnol; 2019 Jun; 35(6):94. PubMed ID: 31187291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence factors of Pseudomonas aeruginosa.
    Döring G; Maier M; Müller E; Bibi Z; Tümmler B; Kharazmi A
    Antibiot Chemother (1971); 1987; 39():136-48. PubMed ID: 3118780
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adjuvant therapy with pseudomonas immunoglobulin in artificially ventilated patients at a surgical intensive care unit].
    Class I; Schorer R
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):167-71. PubMed ID: 2504072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.